On May 6, 2020 Boston Scientific Corporation (NYSE: BSX) reported that it will participate in three upcoming virtual investor conferences (Press release, Boston Scientific, MAY 6, 2020, View Source [SID1234557193]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On May 13, 2020, Dan Brennan, executive vice president and chief financial officer, and Susie Lisa, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at the BofA Securities 2020 Health Care Conference. The session will begin at approximately 8:20 a.m. EDT.

On May 19, 2020, Jeff Mirviss, executive vice president and president, Peripheral Interventions, Michael Jaff, D.O., vice president, clinical affairs, innovation and technology, Peripheral Interventions, and Susie Lisa will participate in a 40-minute question-and-answer session with the host analyst at the UBS Global Healthcare Conference. The session will begin at approximately 9:10 a.m. EDT.

On May 27, 2020, Mike Mahoney, chairman and chief executive officer, and Susie Lisa will participate in a 50-minute question-and-answer session with the host analyst at Bernstein’s 36th Annual Strategic Decisions Conference. The session will begin at approximately 8 a.m. EDT.

A live webcast and replay of the webcast for each event will be accessible at investors.bostonscientific.comView Source The replay will be available beginning approximately one hour following the completion of each event.